The effectiveness of buprenorphine-naloxone on opioid use disorder
Author
Faculty Advisor
Date
2022
Keywords
opioid use disorder, buprenorphine-naloxone, opioid replacement therapy
Abstract (summary)
Opioid use disorder (OUD) is a disorder characterized by extreme opioid misuse which causes issues within all aspects of life. To treat OUD, buprenorphine-naloxone (BNX) is used as a partial opioid agonist paired with naloxone to discourage injection. This medication is often prescribed as a sublingual medication for participants to self-administer. This paper investigates the effectiveness of BNX on treating OUD by examining various empirical studies concerning BNX. The studies suggest BNX has a moderate to strong effectiveness on treating OUD compared to other available treatments. Future directions primarily consist of addressing the common limitation of low retention rates in treatment through a variety of means. Assessment of BNX on OUD is necessary as the opioid crisis present in North America continues to grow.
Publication Information
DOI
Notes
This work was submitted for an assignment in PSYC 399 on November 28, 2022 at MacEwan University located in Edmonton, Alberta.
Item Type
Student Report
Language
Rights
All Rights Reserved